Journal articles on the topic 'Banned Drug'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Banned Drug.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Hunter, Elizabeth. "Drug not banned." New Scientist 197, no. 2641 (2008): 18. http://dx.doi.org/10.1016/s0262-4079(08)60276-6.
Full textVaishnavi S, Ghodake, Hangargekar Sachin, Yelkote Priyanka D, et al. "A Review on Banned Drugs." Asian Journal of Pharmaceutical Research and Development 11, no. 6 (2023): 31–35. http://dx.doi.org/10.22270/ajprd.v11i6.1331.
Full textAvnish, Rajak* Kavita Lovanshi Rita Mourya. "A Review of Adverse Effects of Banned Drugs in India." International Journal of Pharmaceutical Sciences 3, no. 4 (2025): 3139–46. https://doi.org/10.5281/zenodo.15295454.
Full textAmbrose, Peter J., Candy Tsourounis, Rachel Olander, and Frank Uryasz. "Characteristics of Drug and Dietary Supplement Inquiries by College Athletes." Sports Health: A Multidisciplinary Approach 2, no. 1 (2009): 12–18. http://dx.doi.org/10.1177/1941738109347978.
Full textCadwallader, Amy B., and Bob Murray. "Performance-Enhancing Drugs I: Understanding the Basics of Testing for Banned Substances." International Journal of Sport Nutrition and Exercise Metabolism 25, no. 4 (2015): 396–404. http://dx.doi.org/10.1123/ijsnem.2014-0185.
Full textMalaki, Majid. "Sibutramine: A banned innocent antiobesity drug." Journal of Pharmaceutical Negative Results 7, no. 1 (2016): 53. http://dx.doi.org/10.4103/0976-9234.177078.
Full textSiegel-Itzkovich, J. "Doctors banned from drug company trip." BMJ 317, no. 7155 (1998): 370. http://dx.doi.org/10.1136/bmj.317.7155.370a.
Full textAli, Imran, Waseem A. Wani, Kishwar Saleem, and Ashanul Haque. "Thalidomide: A Banned Drug Resurged into Future Anticancer Drug." Current Drug Therapy 7, no. 1 (2012): 13–23. http://dx.doi.org/10.2174/157488512800389164.
Full textCeprudin, Ceprudin, Retno Mawarini Sukmariningsih, Sri Mulyani, Afif Noor, Dwi Wulandari, and Ali Maskur. "Government Responsibility in Managing Illegal Drug Circulation During the Covid-19 Pandemic." WSEAS TRANSACTIONS ON SYSTEMS 22 (March 24, 2023): 304–12. http://dx.doi.org/10.37394/23202.2023.22.33.
Full textLee, Sang-Yong, Jae-Hyeon Park, Jiwun Yoon, and Ji-Yong Lee. "A Validation Study of a Deep Learning-Based Doping Drug Text Recognition System to Ensure Safe Drug Use among Athletes." Healthcare 11, no. 12 (2023): 1769. http://dx.doi.org/10.3390/healthcare11121769.
Full textWadman, Meredith. "Banned drug ‘still used until this month’." Nature 392, no. 6679 (1998): 853. http://dx.doi.org/10.1038/31777.
Full textSidley, P. "Researchers' offices raided over banned AIDS drug." BMJ 315, no. 7121 (1997): 1485–88. http://dx.doi.org/10.1136/bmj.315.7121.1485c.
Full textMeher, Bikash Ranjan, Smita Das, and Rashmi Ranjan Mohanty. "Meldonium: drug which brought disrepute to sport." International Journal of Basic & Clinical Pharmacology 6, no. 8 (2017): 1841. http://dx.doi.org/10.18203/2319-2003.ijbcp20173267.
Full textWangge, Grace, Olaf H. Klungel, Kit C. B. Roes, Anthonius de Boer, Arno W. Hoes, and Mirjam J. Knol. "Should non-inferiority drug trials be banned altogether?" Drug Discovery Today 18, no. 11-12 (2013): 601–4. http://dx.doi.org/10.1016/j.drudis.2013.01.003.
Full textAishwarya, Rathod Kavita M. Jaiswal Sujata Dudhgaonkar Latesh B. Raghute Nandkishore Jaiswal. "Evaluation Of Knowledge, Attitude And Practices Of Pharmacovigilance In Health Care Professionals Of Tertiary Care Teaching Institute In Tribal Region Of Central India." British Journal of BioMedical Research 03, no. 03 (2019): 873–81. https://doi.org/10.24942/bjbmr.2019.488.
Full textBeotra, Alka. "Drug Abuse in Sports: An Overview." Journal of Postgraduate Medicine, Education and Research 47, no. 2 (2013): 94–98. http://dx.doi.org/10.5005/jp-journals-10028-1063.
Full textAnizan, Sebastien, and Marilyn A. Huestis. "The Potential Role of Oral Fluid in Antidoping Testing." Clinical Chemistry 60, no. 2 (2014): 307–22. http://dx.doi.org/10.1373/clinchem.2013.209676.
Full textNilesh, Borse* Dusane G. V. Kawade R. M. "Paracetamol, Mefenamic Acid and Phenylephrine Hydrochloride Study of The Toxicity." International Journal of Pharmaceutical Sciences 2 (December 7, 2024): 584–607. https://doi.org/10.5281/zenodo.14292795.
Full textDafny, Leemore, Kate Ho, and Edward Kong. "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?" American Economic Journal: Economic Policy 16, no. 3 (2024): 314–46. http://dx.doi.org/10.1257/pol.20220355.
Full textJosefson, D. "Hay fever drug to be banned by the FDA." BMJ 314, no. 7076 (1997): 247. http://dx.doi.org/10.1136/bmj.314.7076.247c.
Full textKOREN, GIDEON. "Errors in Drug Administration." Pediatrics 79, no. 1 (1987): 171–72. http://dx.doi.org/10.1542/peds.79.1.171.
Full textLiao, Judy, and Pirkko Markula. "“The Only Thing I Am Guilty of Is Taking Too Many Jump Shots1”: A Deleuzian Media Analysis of Diana Taurasi’s Drug Charge in 2010." Sociology of Sport Journal 33, no. 2 (2016): 169–79. http://dx.doi.org/10.1123/ssj.2015-0079.
Full textCatlin, D. H., R. C. Kammerer, C. K. Hatton, M. H. Sekera, and J. L. Merdink. "Analytical chemistry at the Games of the XXIIIrd Olympiad in Los Angeles, 1984." Clinical Chemistry 33, no. 2 (1987): 319–27. http://dx.doi.org/10.1093/clinchem/33.2.319.
Full textSøgaard, Thomas Friis. "Voices of the Banned." Contemporary Drug Problems 45, no. 1 (2017): 15–32. http://dx.doi.org/10.1177/0091450917741918.
Full textOzdemir, Mehmet, Cuneyt Sensoy, and Gulen Vural. "Damage and Morphometric Effects of Prohibited Substance Use as Doping on Tissues and Organs." Eurasia Proceedings of Health, Environment and Life Sciences 14 (September 1, 2024): 49–60. https://doi.org/10.55549/ephels.127.
Full textBin Khalid, Muhammad Moaz, and Muhammad Nouman. "Nimesulide: A double-edged sword must be banned." Journal of the Pakistan Medical Association 73, no. 12 (2023): 2511. http://dx.doi.org/10.47391/jpma.9593.
Full textSathish Kumar B., Rohan A., and Naveen Gowda B. "Analysis of fixed dose combinations of expectorants, antitussives, decongestants, antihistamines and mucolytics available in the Indian market for rationality and cost variation." International Journal of Basic & Clinical Pharmacology 12, no. 3 (2023): 422–26. http://dx.doi.org/10.18203/2319-2003.ijbcp20231122.
Full textJoshi, Nupuri, Anvita Falke, Sajin Saji, Arundhati Diwan, and Asawari Raut. "Evaluation of prescribing pattern and rationality of fixed dose combinations in patients of general medicine department." International Journal of Basic & Clinical Pharmacology 9, no. 1 (2019): 122. http://dx.doi.org/10.18203/2319-2003.ijbcp20195773.
Full textNaikwadi, Shagupta A., and Rupali B. Jadhav. "Nimesulide induced Stevens Johnson Syndrome: a case report." International Journal of Basic & Clinical Pharmacology 6, no. 8 (2017): 2094. http://dx.doi.org/10.18203/2319-2003.ijbcp20173303.
Full textBhargavi, R., V. T. Hemalatha, A. Amudhan, T. Sarumathi, and T. Manigandan. "Banned Fixed Drug Combinations of NSAIDS:An Update for Dentists in India." Indian Journal of Public Health Research & Development 10, no. 12 (2019): 1009. http://dx.doi.org/10.37506/v10/i12/2019/ijphrd/192258.
Full textThevis, Mario, Tiia Kuuranne, Hans Geyer, and Wilhelm Schänzer. "Annual banned-substance review: analytical approaches in human sports drug testing." Drug Testing and Analysis 5, no. 1 (2012): 1–19. http://dx.doi.org/10.1002/dta.1441.
Full textThevis, Mario, Tiia Kuuranne, Hans Geyer, and Wilhelm Schänzer. "Annual banned-substance review: analytical approaches in human sports drug testing." Drug Testing and Analysis 6, no. 1-2 (2013): 164–84. http://dx.doi.org/10.1002/dta.1591.
Full textThevis, Mario, Tiia Kuuranne, Hans Geyer, and Wilhelm Schänzer. "Annual banned-substance review: analytical approaches in human sports drug testing." Drug Testing and Analysis 7, no. 1 (2014): 1–20. http://dx.doi.org/10.1002/dta.1769.
Full textThevis, Mario, Tiia Kuuranne, Katja Walpurgis, Hans Geyer, and Wilhelm Schänzer. "Annual banned-substance review: analytical approaches in human sports drug testing." Drug Testing and Analysis 8, no. 1 (2016): 7–29. http://dx.doi.org/10.1002/dta.1928.
Full textThevis, Mario, Tiia Kuuranne, Hans Geyer, and Wilhelm Schänzer. "Annual banned-substance review: analytical approaches in human sports drug testing." Drug Testing and Analysis 9, no. 1 (2017): 6–29. http://dx.doi.org/10.1002/dta.2139.
Full textThevis, Mario, Tiia Kuuranne, and Hans Geyer. "Annual banned-substance review: Analytical approaches in human sports drug testing." Drug Testing and Analysis 10, no. 1 (2017): 9–27. http://dx.doi.org/10.1002/dta.2336.
Full textThevis, Mario, Tiia Kuuranne, Hans Geyer, and Wilhelm Schänzer. "Annual banned-substance review: analytical approaches in human sports drug testing." Drug Testing and Analysis 3, no. 1 (2011): 1–14. http://dx.doi.org/10.1002/dta.245.
Full textThevis, Mario, Tiia Kuuranne, and Hans Geyer. "Annual banned-substance review: Analytical approaches in human sports drug testing." Drug Testing and Analysis 11, no. 1 (2019): 8–26. http://dx.doi.org/10.1002/dta.2549.
Full textThevis, Mario, Tiia Kuuranne, and Hans Geyer. "Annual banned‐substance review – Analytical approaches in human sports drug testing." Drug Testing and Analysis 12, no. 1 (2020): 7–26. http://dx.doi.org/10.1002/dta.2735.
Full textThevis, Mario, Tiia Kuuranne, Hans Geyer, and Wilhelm Schänzer. "Annual banned-substance review: analytical approaches in human sports drug testing." Drug Testing and Analysis 4, no. 1 (2012): 2–16. http://dx.doi.org/10.1002/dta.415.
Full textThevis, Mario, Tiia Kuuranne, Hans Geyer, and Wilhelm Schänzer. "Annual banned-substance review: analytical approaches in human sports drug testing." Drug Testing and Analysis 2, no. 4 (2010): 149–61. http://dx.doi.org/10.1002/dta.128.
Full textTsai, Ming-Yang, Chuen-Fu Lin, Wei-Cheng Yang, Chien-Teng Lin, Kuo-Hsiang Hung, and Geng-Ruei Chang. "Health Risk Assessment of Banned Veterinary Drugs and Quinolone Residues in Shrimp through Liquid Chromatography–Tandem Mass Spectrometry." Applied Sciences 9, no. 12 (2019): 2463. http://dx.doi.org/10.3390/app9122463.
Full textPrioste, Tassia, Thiago Ferreira dos Santos Magon, Vinicius Fagundes, Maiara Camotti Montanha, Cristiane Moriwaki, and Elza Kimura. "Recovery of drug residues in equipment and utensils used by compounding pharmacies after standard cleaning procedure." Brazilian Journal of Pharmaceutical Sciences 51, no. 2 (2015): 317–22. http://dx.doi.org/10.1590/s1984-82502015000200008.
Full textKumar, Vineet, Manju Gari, Kishor Chakraborty, Ravi Ranjan, Anshuman Chandra, and Kavita Kumari. "Nimesulide induced toxic epidermal necrolysis: a rare case report." International Journal of Basic & Clinical Pharmacology 6, no. 12 (2017): 2939. http://dx.doi.org/10.18203/2319-2003.ijbcp20175223.
Full textAprajita, Rastogi, and Ramesh K. Goyal Prof. "Ban of Fixed Dose Combination on India Impact and Implications." International Journal of Trend in Scientific Research and Development 3, no. 5 (2019): 352–56. https://doi.org/10.5281/zenodo.3589769.
Full textAher, Kartiki, Smita A. Tiwari, and Prerana M. Kadam. "Knowledge and Attitude Regarding Pharmacovigilance in General Population." Indian Journal of Public Health Research & Development 15, no. 4 (2024): 183–89. http://dx.doi.org/10.37506/b1v3yh30.
Full textR, Joan Vijetha, Kaviyarasan K, Annie Bhuvana Mary A, Gopinath N, Sam Daniel J, and Vasanth B. "Metformin hydrochloride: The most prescribed treatment for type II diabetes -gets banned." Future Journal of Pharmaceuticals and Health Sciences 4, no. 1 (2024): 102–9. http://dx.doi.org/10.26452/fjphs.v4i1.585.
Full textR, Joan Vijetha. "Metformin hydrochloride: The most prescribed treatment for type II diabetes -gets banned." Metformin hydrochloride: The most prescribed treatment for type II diabetes -gets banned 4, no. 1 (2024): 102–9. https://doi.org/10.5281/zenodo.14649952.
Full textKurowska, Patrycja, and Wojciech Giermaziak. "Safety of Metamizole Therapy." Biuletyn Głównej Biblioteki Lekarskiej 56, no. 380 (2023): 55–70. https://doi.org/10.2478/bgbl-2023-0003.
Full textWhite, C. Michael. "Dietary Supplements Pose Real Dangers to Patients." Annals of Pharmacotherapy 54, no. 8 (2020): 815–19. http://dx.doi.org/10.1177/1060028019900504.
Full text